At present, there are more than 2.2 million Australians living osteoarthritis (OA), a joint disease which causes chronic pain, and rates continue to soar.

A leading osteoarthritis expert says too often patients receive fragmented and inappropriate care to manage their damaged joints. Professor David Hunter is leading a national strategy to significantly improve the way patients with osteoarthritis are managed. 

DURING last month's World Arthritis Day, the Australian Physiotherapy Association called for increased treatment access for sufferers. Osteoarthritis (OA) is the most common chronic joint disease, and one of the leading causes of pain and disability in Australia.

An early ACL injury is painful, costly and can lead to long term health issues, with lasting impacts on employment and ability to exercise, says local MP Anoulack Chanthivong.

A new educational topic on low back pain from NPS MedicineWise could reframe the role of imaging in diagnosing non-specific low back pain, providing practice tips on how to manage consumer beliefs and expectations.

Osteoarthritis, or OA, is the most common form of arthritis, affecting more than 2.1 million Australians.

Osteoarthritis (OA) is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia’s population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 2030¹.

The Australian Physiotherapy Association has made several key recommendations to the MBS review to increase access and equity to services, and reduce unnecessary red tape in the healthcare system.

The Australian Physiotherapy Association (APA) expressed its strong opposition to the National Disability Insurance Agency acceptance of the Independent Pricing Review from McKinsey & Company.